Economic Considerations of Platform Trials for Clinical Development Programs in Multi-sponsor and Single-sponsor Settings
Olivier Collignon, Jay JH Park, T Ashton, Jonathan Wright et autres
0 citations
T Ashton
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
28Publications signalées
789Citations signalées
0Affiliations récentes
Domaines associés
Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and EfficacyExercise and Physiological ResponsesSports Performance and TrainingMuscle metabolism and nutrition
Publications récentes
Unmasking the Silent Storm: Hypertension in Pregnancy, Recurrent Takotsubo Cardiomyopathy, and the Hidden Threat of Phaeochromocytoma
Aravind Krishnan, Reza Reyaldeen, T Ashton, P. Challa et autres
0 citationsHeart Lung and Circulation
PD-L1+ plasma cells suppress T lymphocyte responses in patients with sepsis and mouse sepsis models
Morgane Gossez, Clara Vigneron, Alexandra Vandermoeten, Margot Lepage et autres
26 citationsNature Communications
Integrated clustering of multiple immune marker trajectories reveals different immunotypes in severely injured patients
Maxime Bodinier, Estelle Peronnet, Jean-François Llitjos, Louis Kreitmann et autres
20 citationsCritical Care
A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score
Jan-Alexis Tremblay, Florian Peron, Louis Kreitmann, Julien Textoris et autres
41 citationsAnnals of Intensive Care
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net
Marlieke E.A. de Kraker, Harriet Sommer, Femke de Velde, Isaac Gravestock et autres
35 citationsClinical Infectious Diseases
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
William O’Riordan, Courtney Tiffany, Nicole E. Scangarella-Oman, Caroline Perry et autres
82 citationsAntimicrobial Agents and Chemotherapy
Improving perfusion fluid for the next generation of transplants: Identifying agents that lower cellular oxygen consumption and reduce tissue hypoxia
Abul Siddiky, Pavitra Kannan, Daniel T. Grimes, T Ashton et autres
0 citationsOxford University Research Archive (ORA) (University of Oxford)
Utilizing a Clinical Utility Index in a Phase 2, Randomized, Bayesian Response-Adaptive Design to Study the Efficacy and Safety of Gepotidacin (GSK2140944) in Patients With Acute Bacterial Skin and Skin Structure Infections
T Ashton, Ohad Amit, Étienne Dumont, Nicole E. Scangarella-Oman et autres
0 citationsOpen Forum Infectious Diseases
Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in Patients With Acute Bacterial Skin and Soft Structure Infections from a Phase 2 Randomized, Adaptive-Design, Dose-Ranging Study
William O’Riordan, Courtney Tiffany, Nicole E. Scangarella-Oman, Caroline Perry et autres
2 citationsOpen Forum Infectious Diseases
In Vitro Activity and Microbiological Efficacy of Gepotidacin (GSK2140944): A Phase 2, Randomized, Multicenter, Dose-Ranging Study in Patients With Acute Bacterial Skin and Skin Structure Infections
Nicole E. Scangarella-Oman, Karen Ingraham, Courtney Tiffany, Caroline Perry et autres
1 citationOpen Forum Infectious Diseases
Molecular detection of exercise-induced free radicals following ascorbate prophylaxis in type 1 diabetes mellitus: a randomised controlled trial
Gareth W. Davison, T Ashton, Lindsay George, Ian Young et autres
33 citationsDiabetologia
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.